RESTOCYTE

Serial Number 98941857
606

Registration Progress

Application Filed
Jan 7, 2025
Under Examination
Jun 10, 2025
Approved for Publication
Apr 15, 2025
Published for Opposition
Apr 15, 2025
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Mar 12, 2026 29 days
Revival assistance for abandoned trademark

Trademark Image

RESTOCYTE

Basic Information

Serial Number
98941857
Filing Date
January 7, 2025
Published for Opposition
April 15, 2025
Abandonment Date
January 12, 2026
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 12, 2026
Classes
005

Rights Holder

LIFECYTE INNOVATIONS, LLC

16
Address
3150 PINNEY WOODS COURT SE
CEDAR RAPIDS, IA 52403

Ownership History

BROMO, LLC

Original Applicant
16
Cedar Rapids, IA

BROMO, LLC

Owner at Publication
16
Cedar Rapids, IA

LIFECYTE INNOVATIONS, LLC

New Owner After Publication #1
16
CEDAR RAPIDS, IA

Legal Representation

Attorney
Brett D. Papendick

USPTO Deadlines

Next Deadline
29 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
March 12, 2026

Application History

11 events
Date Code Type Description Documents
Jan 12, 2026 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 12, 2026 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 8, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 10, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 15, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 15, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 9, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 20, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 20, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 7, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 7, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Nutritional supplements for vision health; Pharmaceutical preparations for the treatment of macular degeneration

Classification

International Classes
005